CY1115027T1 - PHARMACEUTICAL COMPOSITION FOR INVESTIGATIVE UAVIS PROTECTION C - Google Patents
PHARMACEUTICAL COMPOSITION FOR INVESTIGATIVE UAVIS PROTECTION CInfo
- Publication number
- CY1115027T1 CY1115027T1 CY20141100267T CY141100267T CY1115027T1 CY 1115027 T1 CY1115027 T1 CY 1115027T1 CY 20141100267 T CY20141100267 T CY 20141100267T CY 141100267 T CY141100267 T CY 141100267T CY 1115027 T1 CY1115027 T1 CY 1115027T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- uavis
- investigative
- protection
- hepatitis
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Αποκαλυπτόμενη είναι φαρμακευτική σύνθεση αναστολέα ιικής πρωτεάσης ηπατίτιδος C, η οποία είναι κατάλληλη για χορήγηση από του στόματος, μέσω κάψουλας γεμάτης με υγρό ή ημι-στερεό και μέθοδοι χρήσης αυτής της σύνθεσης για παρεμπόδιση της αντιγραφής του ιού ηπατίτιδας C (HCV) και για τη θεραπεία μιας HCV μόλυνσης. Η υγρή ή ημι-στερεά φαρμακευτική σύνθεση της παρούσας εφεύρεσης περιλαμβάνει μια ένωση του τύπου I ή ένα φαρμακευτικώς αποδεκτό άλας αυτής, μαζί με ένα ή περισσότερα φαρμακευτικώς αποδεκτά λιπίδια και υδρόφιλα επιφανειοδραστικά.Revealed is a pharmaceutical composition of a hepatitis C virus protease inhibitor, which is suitable for oral administration through a liquid or semi-solid capsule and methods of using this composition to inhibit replication of hepatitis C virus (HCV) and for treatment a HCV infection. The liquid or semi-solid pharmaceutical composition of the present invention comprises a compound of formula I or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable lipids and hydrophilic surfactants.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22350709A | 2009-07-07 | 2009-07-07 | |
EP10731685.3A EP2451438B8 (en) | 2009-07-07 | 2010-07-01 | Pharmaceutical composition for a hepatitis c viral protease inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115027T1 true CY1115027T1 (en) | 2016-12-14 |
Family
ID=58464057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100267T CY1115027T1 (en) | 2009-07-07 | 2014-04-09 | PHARMACEUTICAL COMPOSITION FOR INVESTIGATIVE UAVIS PROTECTION C |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1115027T1 (en) |
-
2014
- 2014-04-09 CY CY20141100267T patent/CY1115027T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2012000009A1 (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
CY1121418T1 (en) | HEPATITIS VIRUS INHIBITORS C | |
EA201992082A1 (en) | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | |
UY37998A (en) | ANTIVIRAL AGENTS AGAINST HEPATITIS B | |
CO2021008055A2 (en) | Heterocycles functionalized as antiviral agents | |
EA201100795A1 (en) | PHARMACEUTICAL COMPOSITION OF EFFICIENT HSG INHIBITOR FOR ORAL ADMINISTRATION | |
CO6511251A2 (en) | CHEMICAL COMPOUNDS | |
CY1115253T1 (en) | CRYSTAL FORMS OF A 2-THIAZOLYL-4-QUINOLINYL-OXY-GROUP PRODUCER | |
BR112015021027A8 (en) | therapeutic compounds, their uses, and pharmaceutical compositions | |
EA201201031A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
CO6592102A2 (en) | Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases | |
EA200901423A1 (en) | BENZIMIDAZOLY AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
UY30819A1 (en) | DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
UY35586A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
CY1112999T1 (en) | DISEASES OF US DIVISION C | |
EA201791019A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
EA201290575A1 (en) | FLAVIVIRIDAE VIRUS INHIBITORS | |
ECSP11011561A (en) | AMINOBUTYRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS | |
UY33183A (en) | INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT | |
CY1122182T1 (en) | IMMUNOSUPPRESSANT PHARMACEUTICAL FORMS | |
EA201491479A1 (en) | DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
UY38383A (en) | HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS | |
EA201490213A1 (en) | BENZOFURANE CONNECTIONS FOR THE TREATMENT OF INFECTIONS BY THE HEPATITIS C VIRUS | |
CY1113240T1 (en) | Salts of HIV Inhibitor Compounds | |
EA201300805A1 (en) | Derivatives of phenyl isoxazole and a method for its preparation |